These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39157746)

  • 1. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series.
    Xiong YJ; Xiao Y; Xie L; Gao L; Han Y; Huang PF; Liu S; Liang YX; Wang H
    Infect Drug Resist; 2024; 17():3491-3499. PubMed ID: 39157746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Successful treatment with contezolid in a patient with tuberculous meningitis who was intolerant to linezolid.
    Xu Z; Zhang J; Guan T; Wan G; Jiang C; Lang L; Wang L
    Front Med (Lausanne); 2023; 10():1224179. PubMed ID: 37928457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study.
    Cui D; Hu X; Shi L; Wang D; Chen G
    J Chemother; 2023 Sep; 35(5):404-410. PubMed ID: 36322121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
    Yang M; Zhan S; Fu L; Wang Y; Zhang P; Deng G
    Drug Discov Ther; 2022 May; 16(2):99-101. PubMed ID: 35418550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid-a typical case report and literature review.
    Li J; Yu Z; Jiang Y; Lao S; Li D
    Front Cell Infect Microbiol; 2023; 13():1258561. PubMed ID: 37908760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review.
    Wang J; Ma L
    Front Med (Lausanne); 2023; 10():1265923. PubMed ID: 38162885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Lifan Z; Sainan B; Feng S; Siyan Z; Xiaoqing L
    Int J Tuberc Lung Dis; 2019 Dec; 23(12):1293-1307. PubMed ID: 31931914
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
    Winchell CG; Mishra BB; Phuah JY; Saqib M; Nelson SJ; Maiello P; Causgrove CM; Ameel CL; Stein B; Borish HJ; White AG; Klein EC; Zimmerman MD; Dartois V; Lin PL; Sassetti CM; Flynn JL
    Front Immunol; 2020; 11():891. PubMed ID: 32477361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Intractable Tuberculous Peritonitis in a Woman with Chronic Kidney Allograft Dysfunction Using Contezolid Containing Regimen.
    Liu W; Yang L; Qin H; Zhang P
    Infect Drug Resist; 2024; 17():2713-2718. PubMed ID: 38974317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome, recurrence and safety of multidrug-resistant TB treated with low-dose linezolid.
    Chung C; Jo KW; Shim TS
    Int J Tuberc Lung Dis; 2023 Dec; 27(12):918-924. PubMed ID: 38042970
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models.
    Liu H; Zhu H; Fu L; Zhang W; Chen X; Wang B; Guo S; Ding Y; Wang N; Li D; Lu Y
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0139922. PubMed ID: 36622240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients.
    Wang J; Nie W; Ma L; Li Q; Geng R; Shi W; Chu N
    Infect Drug Resist; 2023; 16():6237-6245. PubMed ID: 37745897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Concentrations of Contezolid and Its Efficacy and Safety in Elderly Patients with Multidrug-Resistant Tuberculosis and Renal Insufficiency.
    Ma X; Zhang R; Cai X; Lang Y; Wang H; Li J
    Infect Drug Resist; 2024; 17():3047-3056. PubMed ID: 39055543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang S; Cai C; Shen Y; Sun C; Shi Q; Wu N; Zheng S; Qian J; Zhang R; Zhou H
    Front Microbiol; 2021; 12():729900. PubMed ID: 34489919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid in the treatment of extensively drug-resistant tuberculosis.
    Zhang L; Pang Y; Yu X; Wang Y; Gao M; Huang H; Zhao Y
    Infection; 2014 Aug; 42(4):705-11. PubMed ID: 24902521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid induced hypoglycemia and anemia: A case report.
    Lan XH; Hu Y; Cao YJ; Liu P; Ren QT; Zhu WW
    Clin Case Rep; 2023 Aug; 11(8):e7713. PubMed ID: 37529131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB.
    Bano S; Nawaz A; Numan A; Hassan MA; Shafique MBA
    Front Neurol; 2022; 13():908584. PubMed ID: 35812114
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    An H; Sun W; Liu X; Wang T; Qiao J; Liang J
    Microbiol Spectr; 2023 Sep; 11(5):e0462722. PubMed ID: 37732805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.